Peculiarities of the epidemiology of coronavirus infection SARS-CoV-2 at the family medicine level

Podgornaya T.G.; Biryukov V.S.; Shapovalov O.G.; Kirpichova N.B.

All electronic publications

2(142) – III/IV 2021 :

Research article

Peculiarities of the epidemiology of coronavirus infection SARS-CoV-2 at the family medicine level

Podgornaya T.G.¹, Biryukov V.S.², Shapovalov O.G.¹, Kirpichova N.B.¹

Summary. A retrospective analysis the case histories of patients from 42 families (59 children aged 2–18 years and 72 parents) with confirmed SARS-CoV-2 infection was carried out. In the studied contingent of children, the disease proceeded without lung damage with the usual symptom complex of acute respiratory viral infections and did not require inpatient treatment, while 53 adult family members were diagnosed with COVID-associated pneumonia were hospitalized. The data obtained may indicate a potentially manifest role of children as a reservoir and the main carrier of SARS-CoV-2 infection in a large city, as evidenced by a wave of disease among parents after 6.08±0.26 days, while the parents showed a pronounced lesion of the bronchopulmonary system. The aggravating effect of bad habits (smoking), the presence of premorbid/polymorbid pathology on the severity clinical picture in adult patients was confirmed. Social distancing during home isolation within the family showed low efficiency, and the high cost of PCR testing had a negative impact on the timing of diagnosis.

УДК [616.98:578.834.1]-036.22

DOI: 10.32471/umj.1680-3051.142.202157

References:

1. McIntosh K., Hirsch M.S., Bloom A. (2021) COVID-19: Epidemiology, virology, and prevention (https://www.uptodate.com/contents/covid-19-epidemiology-virology-and-prevention).
2. Johns Hopkins University and Medicine (2021) COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU) (https://coronavirus.jhu.edu/map.html).
3. World Health Organization (2021) Coronavirus Disease (COVID-19): Frequently Asked Questions (https://www.who.int/ru/emergencies/diseases/novel-coronavirus-2019/advice-for-public/q-a-coronaviruses).
4. World Health Organization (2020) Questions and answers: Similarities and Differences between COVID-19 and Influenza Pathogens (https://www.who.int/ru/news-room/q-a-detail/q-a-similarities-and-differences-covid-19-and-influenza).
5. World Health Organization (2020) Transmission of SARS-CoV-2: implications for infection prevention precautions (https://www.who.int/publications/i/item/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations).
6. Centers for Disease Control and Prevention (2020) Public Health Guidance for Community-Related Exposure (https://www.cdc.gov/coronavirus/2019-ncov/php/public-health-recommendations.html).
7. Stringhini S., Wisniak A., Piumatti G. et al. et al. (2020) Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet, 396(10247): 313–319. DOI:https://doi.org/10.1016/S0140-6736(20)31304-0.
8. Centers for Disease Control and Prevention (2020) Commercial Laboratory Seroprevalence Surveys (https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/commercial-lab-surveys.html).
9. Havers F.P., Reed C., Lim T. et al. (2020) Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23 — May 12, 2020. JAMA Intern. Med. doi: 10.1001/jamainternmed.2020.4130.
10. Meyerowitz E.A., Richterman A., Gandhi R.T., Sax P.E. (2020) Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors. Ann. Intern. Med. https://doi.org/10.7326/M20-5008.
11. Chagla Z., Hota S., Khan S., Mertz D. (2020) Airborne Transmission of COVID-19. Clin. Infect. Dis. doi: 10.1093/cid/ciaa1118.
12. Klompas M., Baker M.A., Rhee Ch. (2020) Airborne Transmission of SARS-CoV-2: Theoretical Considerations and Available Evidence. JAMA. doi: 10.1001/jama.2020.12458.
13. Lu J., Gu J., Li K. et al. (2020) COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020. Emerg. Infect. Dis., 26(7) (https://wwwnc.cdc.gov/eid/article/26/7/20-0764_article).
14. Shen Y., Li Ch., Dong H. et al. (2020) Community Outbreak Investigation of SARS-CoV-2 Transmission Among Bus Riders in Eastern China. JAMA Intern. Med., 180(12): 1665–1671. doi: 10.1001/jamainternmed.2020.5225.